Clinical Trial: A Phase III Clinical Trial and Extension Study to Evaluate the Efficacy and Safety of DWP14012 for Maintenance Therapy in Patients With Healed Erosive Esophagitis

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746518) titled 'A Phase III Clinical Trial and Extension Study to Evaluate the Efficacy and Safety of DWP14012 for Maintenance Therapy in Patients With Healed Erosive Esophagitis' on July 31.

Brief Summary: A Multi-center, Double-blind, Randomized, Active-controlled, Parallel-group, Phase III Clinical Trial and Open-label Extension Study to Evaluate the Efficacy and Safety of DWP14012 for Maintenance Therapy in Patients with Healed Erosive Esophagitis

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Healed Erosive Esophagitis

Intervention: DRUG: DWP14012 20mg

20mg, 1 tablet, Orally, Once a day

DRUG: DWP14012 20 mg placebo...